查看购物车
  • Traditional Chinese
  • English
2021-2031年亚太地区第二医疗意见市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1843414

2021-2031年亚太地区第二医疗意见市场报告（范围、细分、动态和竞争分析）

Asia Pacific Medical Second Opinion Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 118 Pages | 订单完成后即时交付

价格

亚太地区医疗第二意见市场预计将大幅成长，到 2031 年将达到约 27.2132 亿美元，高于 2023 年的 9.0381 亿美元，在此期间的年复合成长率(CAGR) 为 14.8%。

执行摘要和市场分析

亚太地区被公认为是医疗二次诊疗意见成长最快的市场。该市场主要分布在几个主要国家，包括中国、日本、印度、韩国、澳洲以及亚太地区的其他地区。值得注意的是，中国、印度和日本是该市场成长的主要贡献者。主要驱动因素包括老龄人口成长、慢性病发病率上升以及政府的支持性措施。此外，远距医疗和人工智慧 (AI) 在提供二次诊疗意见方面的日益普及也推动了市场扩张。

市场区隔分析

亚太地区医疗第二意见市场可以根据医疗条件和服务提供者进行细分。

  • 依疾病类型划分：市场分为多种疾病类型，例如癌症、骨科疾病、心臟疾病、神经系统疾病、肾臟疾病、血液系统疾病、慢性阻塞性肺病 (COPD)、器官移植等。 2023 年，癌症领域占据了市场份额的主导地位。
  • 按服务提供者划分：市场也按服务提供者细分，包括医院、健康保险公司和线上服务。医院部门在 2023 年占据了最大的市场。

市场展望

医疗服务与数位平台的融合正在提升数位化咨询的普及度。这一趋势使患者无需前往医疗机构即可获得第二诊疗意见，从而带来便利，改善患者体验并有效管理成本。数位平台支援偏远地区进行咨询，从而增加了与医疗专家的联繫。软体公司与医疗机构之间的合作正在加速医疗咨询服务的数位转型。例如，2021年10月，信诺健康计画宣布扩展其虚拟护理服务，包括数位优先的初级保健和紧急护理。

国家洞察

亚太地区医疗第二意见市场主要涵盖中国、日本、印度、澳洲、韩国等国。 2023年，中国占了最大的市场份额。根据世界卫生组织 (WHO) 统计，截至2020年4月，中国报告新增癌症病例约457万例，癌症死亡病例约300万例。中国每分钟都会诊断出一例新的癌症，其中最常见的癌症类型是肺癌、胃癌、乳癌、甲状腺癌和白血病。

《柳叶刀》杂誌2019年发表的一项研究强调，预计到2040年，中国老龄人口将达到4.02亿，老年人更容易患慢性病，因此准确的诊断至关重要。误诊率很高，一项研究表明，中国约72.97%的罕见疾病患者被误诊，凸显了寻求第二诊疗意见的重要性。

中国人口众多，医疗基础设施先进，加之通讯技术快速发展，使得远距医疗会诊（主要在医院之间）更加便利。中国的远距医疗计画正在提升癌症诊疗水平，尤其是在农村地区。上海的MediStar Health等公司透过电话会议将患者与外国医生联繫起来，而Voycare则开发了一个提供第二医疗意见的线上入口网站，允许患者上传医疗报告供美国医疗保健专业人员审查。在新冠疫情期间，由于旅行限制阻碍了国际医疗服务的获取，这项服务显得尤为重要。

公司简介

亚太地区医疗第二意见市场的主要参与者包括 Second Opinion International、Elite Medical Services、The Cigna Group、Helsana、WorldCare、Vidal Health Insurance TPA Pvt Ltd、2nd.MD、Axa SA、Teladoc Health Inc、Included Health, Inc. 和 Royal Doctors。这些公司正在采取各种策略，例如市场扩张、产品创新和併购，以增强其产品服务并提高市场份额。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：亚太地区第二医疗意见市场格局

  • 概述
  • PEST分析

第五章：亚太地区医疗第二意见市场－主要市场动态

  • 市场驱动因素
    • 越来越重视更好的治疗效果
    • 医疗成本优化的偏好日益增强
  • 市场限制
    • 新兴国家对第二医疗意见缺乏认识且不愿采纳
  • 市场机会
    • 远距医疗技术合作日益增多
  • 未来趋势
    • 医疗咨询服务数位化
  • 驱动因素和限制因素的影响：

第六章：医疗第二意见市场－亚太地区分析

  • 2021-2031年亚太地区第二医疗意见市场收入
  • 亚太地区医疗第二意见市场预测分析

第七章：亚太地区第二医疗意见市场分析－依条件

  • 癌症
  • 骨科疾病
  • 心臟疾病
  • 神经系统疾病
  • 肾臟疾病
  • 血液系统疾病
  • 慢性阻塞性肺病
  • 器官移植
  • 其他的

第八章：亚太地区第二医疗意见市场分析－依服务提供者

  • 医院
  • 健康保险公司
  • 线上服务

第九章：亚太地区第二医疗意见市场－国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第十章：产业格局

  • 概述
  • 市场倡议
  • 伙伴关係与合作

第 11 章：公司简介

  • Second Opinion International
  • Elite Medical Services
  • The Cigna Group
  • Helsana
  • WorldCare
  • Vidal Health Insurance TPA Pvt Ltd
  • 2nd.MD
  • Axa SA
  • Teladoc Health Inc
  • Included Health, Inc.
  • Royal Doctors

第 12 章：附录

Product Code: TIPRE00025235

The Asia Pacific medical second opinion market is projected to grow significantly, reaching approximately US$ 2,721.32 million by 2031, up from US$ 903.81 million in 2023, with a compound annual growth rate (CAGR) of 14.8% during this period.

Executive Summary and Market Analysis

The Asia Pacific region is recognized as the fastest-growing market for medical second opinions. This market is divided into several key countries, including China, Japan, India, South Korea, Australia, and other regions within Asia Pacific. Notably, China, India, and Japan are major contributors to the growth of this market. Key drivers include an increasing elderly population, a rise in chronic diseases, and supportive government initiatives. Furthermore, the growing adoption of telemedicine and artificial intelligence (AI) in providing second opinions is also propelling market expansion.

Market Segmentation Analysis

The Asia Pacific medical second opinion market can be segmented based on medical conditions and service providers.

  • By Condition: The market is categorized into various conditions such as cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. In 2023, the cancer segment dominated the market share.
  • By Service Provider: The market is also segmented by service providers, which include hospitals, health insurance companies, and online services. The hospitals segment held the largest market share in 2023.

Market Outlook

The integration of medical services with digital platforms is enhancing the popularity of digital consultations. This trend allows patients to obtain second opinions without needing to visit healthcare facilities, offering convenience, improved patient experiences, and effective cost management. Digital platforms enable consultations from remote areas, increasing access to medical experts. Collaborations between software companies and healthcare institutions are accelerating the digital transformation of medical consulting services. For instance, in October 2021, Cigna Health Plan announced an expansion of its virtual care services, including digital-first primary care and urgent care.

Country Insights

The Asia Pacific medical second opinion market includes key countries such as China, Japan, India, Australia, South Korea, and others. China accounted for the largest market share in 2023. According to the World Health Organization (WHO), there were approximately 4.57 million new cancer cases and 3 million cancer-related deaths reported in China as of April 2020. The country sees a new cancer diagnosis every minute, with lung, stomach, breast, thyroid cancers, and leukemia being the most prevalent types.

A study published in The Lancet in 2019 highlighted that the aging population in China, projected to reach 402 million by 2040, is more susceptible to chronic diseases, making accurate diagnoses critical. Misdiagnosis rates are high, with a study indicating that about 72.97% of patients with rare diseases in China were misdiagnosed, underscoring the importance of seeking second opinions.

China's vast population and advanced healthcare infrastructure, coupled with rapid communication advancements, facilitate telemedicine consultations primarily between hospitals. Telemedicine programs in China are enhancing cancer diagnosis and treatment, particularly in rural areas. Companies like MediStar Health in Shanghai connect patients with foreign doctors via teleconferencing, while Voycare has developed an online portal for medical second opinions, allowing patients to upload medical reports for review by US healthcare professionals. This service became particularly valuable during the COVID-19 pandemic when travel restrictions hindered access to international medical care.

Company Profiles

Key players in the Asia Pacific medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Asia Pacific Medical Second Opinion Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Asia Pacific Medical Second Opinion Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Emphasis on Better Treatment Outcomes
    • 5.1.2 Increasing Preference for Healthcare Cost Optimization
  • 5.2 Market Restraints
    • 5.2.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
  • 5.3 Market Opportunities
    • 5.3.1 Rising Collaborations in Telemedicine Technologies
  • 5.4 Future Trends
    • 5.4.1 Digitalization of Medical Consulting Services
  • 5.5 Impact of Drivers and Restraints:

6. Medical Second Opinion Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Medical Second Opinion Market Forecast Analysis

7. Asia Pacific Medical Second Opinion Market Analysis - by Condition

  • 7.1 Cancer
    • 7.1.1 Overview
    • 7.1.2 Cancer: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Orthopedic Disorders
    • 7.2.1 Overview
    • 7.2.2 Orthopedic Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Cardiac Disorders
    • 7.3.1 Overview
    • 7.3.2 Cardiac Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Neurological Disorders
    • 7.4.1 Overview
    • 7.4.2 Neurological Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Nephrological Disorders
    • 7.5.1 Overview
    • 7.5.2 Nephrological Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Hematological Blood Disorders
    • 7.6.1 Overview
    • 7.6.2 Hematological Blood Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 COPD
    • 7.7.1 Overview
    • 7.7.2 COPD: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Organ Transplant
    • 7.8.1 Overview
    • 7.8.2 Organ Transplant: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.9 Others
    • 7.9.1 Overview
    • 7.9.2 Others: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Medical Second Opinion Market Analysis - by Service Provider

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Health Insurance Companies
    • 8.2.1 Overview
    • 8.2.2 Health Insurance Companies: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Online Services
    • 8.3.1 Overview
    • 8.3.2 Online Services: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Medical Second Opinion Market - Country Analysis

  • 9.1 Asia Pacific
    • 9.1.1 Asia Pacific Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Asia Pacific Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.2 China: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.2.1 China: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.2.2 China: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.3 Japan: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.3.1 Japan: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.3.2 Japan: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.4 India: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.4.1 India: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.4.2 India: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.5 Australia: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.5.1 Australia: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.5.2 Australia: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.6 South Korea: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.6.1 South Korea: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.6.2 South Korea: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.7 Rest of APAC: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.7.1 Rest of APAC: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.7.2 Rest of APAC: Asia Pacific Medical Second Opinion Market Share - by Service Provider

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Market Initiative
  • 10.3 Partnerships and Collaborations

11. Company Profiles

  • 11.1 Second Opinion International
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Elite Medical Services
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 The Cigna Group
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Helsana
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 WorldCare
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Vidal Health Insurance TPA Pvt Ltd
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 2nd.MD
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Axa SA
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Teladoc Health Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Included Health, Inc.
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Royal Doctors
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 List of Abbreviations

List Of Tables

  • Table 1. Asia Pacific Medical Second Opinion Market Segmentation
  • Table 2. Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Condition
  • Table 4. Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Provider
  • Table 5. Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 6. China: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 7. China: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 8. Japan: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 9. Japan: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 10. India: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 11. India: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 12. Australia: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 13. Australia: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 14. South Korea: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 15. South Korea: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 16. Rest of APAC: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 17. Rest of APAC: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 18. List of Abbreviations

List Of Figures

  • Figure 1. Asia Pacific Medical Second Opinion Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Asia Pacific Medical Second Opinion Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • Figure 6. Asia Pacific Medical Second Opinion Market Share (%) - by Condition (2023 and 2031)
  • Figure 7. Cancer: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Orthopedic Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Cardiac Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Neurological Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Nephrological Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Hematological Blood Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. COPD: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Organ Transplant: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Asia Pacific Medical Second Opinion Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 17. Hospitals: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Health Insurance Companies: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Online Services: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Asia Pacific Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. China: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Japan: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. India: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Australia: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Rest of APAC: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)